Glycopin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGlycopin
Drug Alias Nameglucosaminylmuramyl dipeptideGlucosaminyl muramyl dipeptideLicopidGMDP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPsoriasisLung DiseasesSurgical Wound Infection +[5] 
Global Approved IndicationsPsoriasisLung DiseasesSurgical Wound Infection +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date1996/09/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesTeva Pharmaceutical Industries Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasisLung DiseasesSurgical Wound Infection +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeL03
Related LinksN/A